Health
Health and Pharmaceutical News
The FDA approved Eli Lilly’s Onswik, a once-weekly insulin shot for adults with type 2 diabetes. This new treatment offers an alternative to daily long-acting injections.
Coverage timeline — 1 article
STAT News
The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.
2026-09-25 15:25 UTC